Stada Says Teriparatide Roll-Out Has Been Successful

German Firm Launched In European Markets In August Last Year

Seven months after introducing its teriparatide biosimilar to Eli Lily’s Forsteo into many European markets, Stada is pleased with results and says doctors and patients alike have responded well.

Consultation
Doctors and patients have responded well, Stada says • Source: Shutterstock

More from Biosimilars

More from Products